Photo: Depositphotos
Jun 17, 2025, 08:34
Katsuaki Maehara Shared an Article Published in Signal Transduction and Targeted Therapy on Molecular Pathology and Therapy of NSCLC
Katsuaki Maehara, Director of Medical Education Colleagues, shared on X:
“Advances in molecular pathology and therapy of NSCLC
– Mechanisms involved in cancer cell metastasis in NSCLC
– An algorithm of evidence-based management for stage I-III NSCLC
– Recommended therapy algorithm for oncogene addicted metastatic NSCLC
– Recommended therapy algorithm for non-oncogene addicted metastatic NSCLC
– Resistance mechanisms underlying targeted therapy in NSCLC
– Resistance mechanisms underlying immunotherapy in NSCLC
– Established or developing strategies to overcome drug resistance in NSCLC”
Title: Advances in molecular pathology and therapy of non-small cell lung cancer
Journal: Signal Transduction and Targeted Therapy
Authors: Qing Huang, Yuanxiang Li, Yingdan Huang, Jingyi Wu, Wendai Bao, Chang Xue, Xiaoyu Li, Shuang Dong, Zhiqiang Dong, Sheng Hu
More posts featuring Katsuaki Maehara on OncoDaily.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jul 28, 2025, 16:51
Jul 28, 2025, 16:47
Jul 28, 2025, 16:43
Jul 28, 2025, 16:32
Jul 28, 2025, 16:29
Jul 28, 2025, 16:15
Jul 28, 2025, 16:14
Jul 28, 2025, 15:57
Jul 28, 2025, 15:53